APA

Musto P., Modoni S., Alicino G., Savino A., Longo A., Bodenizza C., Falcone A., D'Arena G., Scalzulli P. & Perla G. (19950425). Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes. : Haematologica.

Chicago

Musto P, Modoni S, Alicino G, Savino A, Longo A, Bodenizza C, Falcone A, D'Arena G, Scalzulli P and Perla G. 19950425. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes. : Haematologica.

Harvard

Musto P., Modoni S., Alicino G., Savino A., Longo A., Bodenizza C., Falcone A., D'Arena G., Scalzulli P. and Perla G. (19950425). Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes. : Haematologica.

MLA

Musto P, Modoni S, Alicino G, Savino A, Longo A, Bodenizza C, Falcone A, D'Arena G, Scalzulli P and Perla G. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes. : Haematologica. 19950425.